{"alopecia": 2.82, "anaemia": 9.85, "ascites": 6.89, "biliary obstruction": 29.97, "blood bilirubin increased": 2.66, "carcinoembryonic antigen increased": 32.22, "constipation": 2.85, "cytopenia": 14.46, "death": 11.5, "decreased appetite": 3.96, "dehydration": 4.58, "diarrhoea": 2.92, "disease progression": 35.48, "febrile neutropenia": 10.9, "full blood count abnormal": 9.77, "general physical health deterioration": 2.54, "haemoglobin decreased": 3.62, "hepatic failure": 3.01, "hospitalisation": 6.7, "inappropriate schedule of product administration": 8.15, "intentional product use issue": 8.0, "intestinal obstruction": 9.1, "jaundice": 2.64, "leukopenia": 8.9, "maligt neoplasm progression": 5.18, "neutropenia": 19.98, "neutrophil count decreased": 4.53, "no adverse event": 2.25, "palmar-plantar erythrodysaesthesia syndrome": 2.6, "pancytopenia": 4.79, "performance status decreased": 7.51, "platelet count decreased": 3.1, "prescribed underdose": 11.74, "product availability issue": 32.58, "product use issue": 4.88, "red blood cell count decreased": 8.89, "septic shock": 2.08, "small intestinal obstruction": 13.38, "taste disorder": 2.45, "thrombocytopenia": 4.92, "transfusion": 11.57, "urinary tract infection": 2.85, "vomiting": 2.13, "weight decreased": 2.87, "white blood cell count decreased": 6.91}